• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子间相互作用作为衡量美洛昔康与羧酸共结晶时水溶性优势的直接指标。

Intermolecular interaction as a direct measure of water solubility advantage of meloxicam cocrystalized with carboxylic acids.

作者信息

Cysewski Piotr

机构信息

Department of Physical Chemistry, Pharmacy Faculty, Collegium Medicum of Bydgoszcz, Nicolaus Copernicus University in Toruń, Kurpińskiego 5, 85-096, Bydgoszcz, Poland.

出版信息

J Mol Model. 2018 Apr 21;24(5):112. doi: 10.1007/s00894-018-3649-0.

DOI:10.1007/s00894-018-3649-0
PMID:29680958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5911280/
Abstract

The solubility advantage (SA) of meloxicam cocrystalized with mono- and dicarboxylic acids was expressed in terms of equilibrium constants involving active pharmaceutical ingredient and coformer in aqueous solutions. It is argued that SA can be quantified by concentration of pairs formed in water. The pH and concentration of dissolved components is included explicitly in the model. The alternative behavior of mono- and dicarboxylic acids was emphasized and addressed to different structural motifs. The structural and energetic properties of meloxicam and its complexes with carboxylic acids were characterized, including tautmerism and dissociation in aqueous media. In particular, performed in silico modeling confirmed experimental observation that meloxicam dissolved in water or modest acidic solutions is expected to be a mixture of anionic form in equilibrium with at least five neutral isomers. Tautomer-related diversity of pairs formation and the possibility of salt formation is also discussed. Graphical abstract Two types of motifs found in meloxicam cocrystals reveal two sources of solubility advantage.

摘要

美洛昔康与一元和二元羧酸共结晶的溶解度优势(SA)通过涉及活性药物成分和共形成剂在水溶液中的平衡常数来表示。有人认为,SA可以通过水中形成的配对物浓度来量化。该模型明确包含了溶解成分的pH值和浓度。强调了一元和二元羧酸的不同行为,并针对不同的结构 motif 进行了探讨。对美洛昔康及其与羧酸复合物的结构和能量性质进行了表征,包括在水性介质中的互变异构和离解。特别是,计算机模拟证实了实验观察结果,即溶解在水或适度酸性溶液中的美洛昔康预计是阴离子形式与至少五种中性异构体处于平衡的混合物。还讨论了与互变异构相关的配对物形成多样性以及形成盐的可能性。图形摘要 在美洛昔康共晶体中发现的两种类型的 motif 揭示了溶解度优势的两个来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/51e0a1fe788f/894_2018_3649_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/ab38c3f272a7/894_2018_3649_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/d8e89cefb524/894_2018_3649_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/c2096d6c66e3/894_2018_3649_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/2ea9cd9c52b6/894_2018_3649_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/974b4529bec4/894_2018_3649_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/51e0a1fe788f/894_2018_3649_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/ab38c3f272a7/894_2018_3649_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/d8e89cefb524/894_2018_3649_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/c2096d6c66e3/894_2018_3649_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/2ea9cd9c52b6/894_2018_3649_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/974b4529bec4/894_2018_3649_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/951c/5911280/51e0a1fe788f/894_2018_3649_Fig5_HTML.jpg

相似文献

1
Intermolecular interaction as a direct measure of water solubility advantage of meloxicam cocrystalized with carboxylic acids.分子间相互作用作为衡量美洛昔康与羧酸共结晶时水溶性优势的直接指标。
J Mol Model. 2018 Apr 21;24(5):112. doi: 10.1007/s00894-018-3649-0.
2
Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation.通过多组分晶体形成提高美洛昔康的溶解度和药代动力学。
Mol Pharm. 2012 Jul 2;9(7):2094-102. doi: 10.1021/mp300169c. Epub 2012 Jun 4.
3
Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.与二羧酸形成的盐和共晶的西地那非:戊二酸盐的溶解度和药代动力学优势。
Mol Pharm. 2013 Dec 2;10(12):4687-97. doi: 10.1021/mp400516b. Epub 2013 Nov 8.
4
Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.药物共晶开发中的共晶形成剂选择:以具有增强溶解性和药代动力学的美洛昔康-阿司匹林共晶为例。
J Pharm Sci. 2011 Jun;100(6):2172-81. doi: 10.1002/jps.22434. Epub 2010 Dec 22.
5
In silico screening of dicarboxylic acids for cocrystallization with phenylpiperazine derivatives based on both cocrystallization propensity and solubility advantage.基于共结晶倾向和溶解度优势,对二元羧酸与苯基哌嗪衍生物共结晶进行计算机模拟筛选。
J Mol Model. 2017 Apr;23(4):136. doi: 10.1007/s00894-017-3287-y. Epub 2017 Mar 27.
6
Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.通过在弱有机酸浓水溶液中增溶并干燥制备的伊曲康唑固体分散体的表征
Pharm Res. 2016 Jun;33(6):1456-71. doi: 10.1007/s11095-016-1890-8. Epub 2016 Mar 7.
7
Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug.利用共晶来系统地调节一种抗癌药物在水中的溶解度和熔融行为。
J Am Chem Soc. 2009 Dec 2;131(47):17048-9. doi: 10.1021/ja907674c.
8
Solid-state acid-base interactions in complexes of heterocyclic bases with dicarboxylic acids: crystallography, hydrogen bond analysis, and 15N NMR spectroscopy.杂环碱与二元羧酸配合物中的固态酸碱相互作用:晶体学、氢键分析和¹⁵N核磁共振光谱
J Am Chem Soc. 2006 Jun 28;128(25):8199-210. doi: 10.1021/ja0541332.
9
Selective Na(+)/K(+) effects on the formation of α-cyclodextrin complexes with aromatic carboxylic acids: competition for the guest.对芳基羧酸与α-环糊精形成包合物的选择性 Na(+)/K(+) 效应:客体竞争。
J Phys Chem B. 2010 Oct 7;114(39):12607-13. doi: 10.1021/jp1063512.
10
pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.在水介质中,依托 pH 值的变化,吲哚美辛-糖精和卡马西平-糖精共晶的溶解度。
Mol Pharm. 2012 Sep 4;9(9):2605-12. doi: 10.1021/mp300189b. Epub 2012 Aug 23.

引用本文的文献

1
Experimental and Theoretical Insights into the Intermolecular Interactions in Saturated Systems of Dapsone in Conventional and Deep Eutectic Solvents.对氨苯砜在传统溶剂和深共熔溶剂饱和体系中分子间相互作用的实验与理论见解
Molecules. 2024 Apr 11;29(8):1743. doi: 10.3390/molecules29081743.
2
Binary Mixtures of Meloxicam and L-Tartaric Acid for Oral Bioavailability Modulation of Pharmaceutical Dosage Forms.用于调节药物剂型口服生物利用度的美洛昔康与L-酒石酸二元混合物
J Funct Biomater. 2024 Apr 16;15(4):104. doi: 10.3390/jfb15040104.
3
Intermolecular Interactions of Edaravone in Aqueous Solutions of Ethaline and Glyceline Inferred from Experiments and Quantum Chemistry Computations.

本文引用的文献

1
Analysis of polymorphic contamination in meloxicam raw materials and its effects on the physicochemical quality of drug product.分析美洛昔康原料药中的多态性污染及其对药物产品理化性质的影响。
Eur J Pharm Sci. 2017 Nov 15;109:347-358. doi: 10.1016/j.ejps.2017.08.029. Epub 2017 Aug 24.
2
Crystal structure of a 2:1 co-crystal of meloxicam with acetyl-endi-carb-oxy-lic acid.美洛昔康与乙酰基-恩地卡羧酸的2:1共晶体的晶体结构
Acta Crystallogr E Crystallogr Commun. 2016 Nov 29;72(Pt 12):1856-1859. doi: 10.1107/S2056989016018909. eCollection 2016 Dec 1.
3
Major Source of Error in QSPR Prediction of Intrinsic Thermodynamic Solubility of Drugs: Solid vs Nonsolid State Contributions?
从实验和量子化学计算推断依达拉奉在乙撑亚胺和甘醇溶液中的分子间相互作用。
Molecules. 2023 Jan 7;28(2):629. doi: 10.3390/molecules28020629.
4
Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs.比格犬体内外性质增强的利伐沙班共晶体的制备、表征及药代动力学
Int J Pharm X. 2022 May 21;4:100119. doi: 10.1016/j.ijpx.2022.100119. eCollection 2022 Dec.
5
Application of the Solute-Solvent Intermolecular Interactions as Indicator of Caffeine Solubility in Aqueous Binary Aprotic and Proton Acceptor Solvents: Measurements and Quantum Chemistry Computations.溶质 - 溶剂分子间相互作用作为咖啡因在二元非质子和质子受体水性溶剂中溶解度指标的应用:测量与量子化学计算
Materials (Basel). 2022 Mar 27;15(7):2472. doi: 10.3390/ma15072472.
6
Multiple linear regression models for predicting the n‑octanol/water partition coefficients in the SAMPL7 blind challenge.用于预测 SAMPL7 盲测中辛醇/水分配系数的多元线性回归模型。
J Comput Aided Mol Des. 2021 Aug;35(8):923-931. doi: 10.1007/s10822-021-00409-2. Epub 2021 Jul 12.
7
The Volumetric Source Function: Looking Inside van der Waals Interactions.体积源函数:探究范德华相互作用的内部。
Sci Rep. 2020 May 8;10(1):7816. doi: 10.1038/s41598-020-64261-4.
药物固有热力学溶解度QSPR预测中的主要误差来源:固态与非固态贡献?
Mol Pharm. 2015 Jun 1;12(6):2126-41. doi: 10.1021/acs.molpharmaceut.5b00119. Epub 2015 Apr 30.
4
Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors.开发具有改善溶解和药代动力学行为的美洛昔康纳米晶体制剂。
Int J Pharm. 2014 Oct 20;474(1-2):151-6. doi: 10.1016/j.ijpharm.2014.08.022. Epub 2014 Aug 17.
5
Is experimental data quality the limiting factor in predicting the aqueous solubility of druglike molecules?实验数据质量是预测类药物分子水溶性的限制因素吗?
Mol Pharm. 2014 Aug 4;11(8):2962-72. doi: 10.1021/mp500103r. Epub 2014 Jul 9.
6
Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel.卡波姆负载美洛昔康纳米脂质体凝胶的抗炎活性增强
Int J Biol Macromol. 2014 Jun;67:99-104. doi: 10.1016/j.ijbiomac.2014.03.011. Epub 2014 Mar 19.
7
Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation.通过多组分晶体形成提高美洛昔康的溶解度和药代动力学。
Mol Pharm. 2012 Jul 2;9(7):2094-102. doi: 10.1021/mp300169c. Epub 2012 Jun 4.
8
Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.药物共晶开发中的共晶形成剂选择:以具有增强溶解性和药代动力学的美洛昔康-阿司匹林共晶为例。
J Pharm Sci. 2011 Jun;100(6):2172-81. doi: 10.1002/jps.22434. Epub 2010 Dec 22.
9
TmoleX--a graphical user interface for TURBOMOLE.TmoleX——用于 TURBOMOLE 的图形用户界面。
J Comput Chem. 2010 Dec;31(16):2967-70. doi: 10.1002/jcc.21576.
10
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.研究改善难溶性美洛昔康溶解性能的制备参数。
Int J Pharm. 2009 Nov 3;381(2):153-9. doi: 10.1016/j.ijpharm.2009.07.009. Epub 2009 Jul 17.